High-affinity target binding engineered via fusion of a single-domain antibody fragment with a ligand-tailored SH3 domain.
Monoclonal and recombinant antibodies are ubiquitous tools in diagnostics, therapeutics, and biotechnology. However, their biochemical properties lack optimal robustness, their bacterial production is not easy, and possibilities to create multifunctional fusion proteins based on them are limited. Mo...
Guardado en:
Autores principales: | Annika Järviluoma, Tomas Strandin, Sebastian Lülf, Jérôme Bouchet, Anna R Mäkelä, Matthias Geyer, Serge Benichou, Kalle Saksela |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f5d5bb140c814e85a52a5463f9b77ddf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands
por: Edmond M. Linossi, et al.
Publicado: (2021) -
Grb2 carboxyl-terminal SH3 domain can bivalently associate with two ligands, in an SH3 dependent manner
por: Richa Arya, et al.
Publicado: (2017) -
SH3 domain tyrosine phosphorylation--sites, role and evolution.
por: Zuzana Tatárová, et al.
Publicado: (2012) -
Protein context shapes the specificity of SH3 domain-mediated interactions in vivo
por: Ugo Dionne, et al.
Publicado: (2021) -
Identification and characterization of a large family of superbinding bacterial SH2 domains
por: Tomonori Kaneko, et al.
Publicado: (2018)